uPVC-Net: A Universal Premature Ventricular Contraction Detection Deep Learning Algorithm
Hagai Hamami, Yosef Solewicz, Daniel Zur, Yonatan Kleerekoper, Joachim A. Behar
TL;DR
This work tackles the challenge of reliably detecting premature ventricular contractions (PVCs) from single-lead ECGs across diverse sensors and populations. The authors introduce uPVC-Net, a universal detector built on a Bi-GRU backbone that processes 8-second Mel-spectrogram segments and is trained with a multi-source, multi-lead strategy to bolster out-of-distribution generalization. Evaluated on four independent datasets totaling 8.3 million beats, uPVC-Net achieves high AUROC values (97.8%–99.1%), with wearables reaching 99.1%, demonstrating robust performance across lead configurations and devices. The study also provides ablation, error analyses, and a benchmark comparison, highlighting practical implications for continuous PVC monitoring in wearables and real-world clinical workflows.
Abstract
Introduction: Premature Ventricular Contractions (PVCs) are common cardiac arrhythmias originating from the ventricles. Accurate detection remains challenging due to variability in electrocardiogram (ECG) waveforms caused by differences in lead placement, recording conditions, and population demographics. Methods: We developed uPVC-Net, a universal deep learning model to detect PVCs from any single-lead ECG recordings. The model is developed on four independent ECG datasets comprising a total of 8.3 million beats collected from Holter monitors and a modern wearable ECG patch. uPVC-Net employs a custom architecture and a multi-source, multi-lead training strategy. For each experiment, one dataset is held out to evaluate out-of-distribution (OOD) generalization. Results: uPVC-Net achieved an AUC between 97.8% and 99.1% on the held-out datasets. Notably, performance on wearable single-lead ECG data reached an AUC of 99.1%. Conclusion: uPVC-Net exhibits strong generalization across diverse lead configurations and populations, highlighting its potential for robust, real-world clinical deployment.
